NFKB1 and acute respiratory distress syndrome: Lipopolysaccharide (LPS) is often used to induce animal models of ARDS LPS binds to TLR4 receptor complex on cell membranes, increases activation of NF-κB and subsequent proinflammatory and prooxidative pathways [23] followed by ARDS-like tissue changes [24,25].